Correlation Between Histogen and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Histogen and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Tempest Therapeutics, you can compare the effects of market volatilities on Histogen and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Tempest Therapeutics.
Diversification Opportunities for Histogen and Tempest Therapeutics
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Histogen and Tempest is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Histogen i.e., Histogen and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Histogen and Tempest Therapeutics
Given the investment horizon of 90 days Histogen is expected to under-perform the Tempest Therapeutics. In addition to that, Histogen is 3.09 times more volatile than Tempest Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 126.00 in Tempest Therapeutics on August 25, 2024 and sell it today you would lose (35.00) from holding Tempest Therapeutics or give up 27.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Histogen vs. Tempest Therapeutics
Performance |
| Timeline |
| Histogen |
| Tempest Therapeutics |
Histogen and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Histogen and Tempest Therapeutics
The main advantage of trading using opposite Histogen and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Histogen vs. Virax Biolabs Group | Histogen vs. Altamira Therapeutics | Histogen vs. Aileron Therapeutics | Histogen vs. Artelo Biosciences |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |